AviadoBio

AviadoBio

Biotechnology Research

London, England 11,662 followers

A revolution in gene therapy for neurodegenerative disorders.

About us

At AviadoBio, we are relentlessly chasing cures by translating groundbreaking science and precision delivery into life-changing medicines for people living with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). With our deep understanding of the brain and our suite of proprietary gene therapy platforms and delivery technologies, we are working relentlessly to overcome the challenges of delivering the right drug to the right place. Our innovative, neuroanatomy-led approach is designed to maximize the therapeutic potential of gene therapy to halt or potentially reverse neurodegenerative diseases. The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.

Website
http://www.aviadobio.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
London, England
Type
Privately Held
Founded
2019

Locations

Employees at AviadoBio

Updates

Similar pages

Browse jobs

Funding

AviadoBio 3 total rounds

Last Round

Corporate round

US$ 20.0M

See more info on crunchbase